Pharmacokinetics and Safety of Inhaled Ivermectin in Mice as a Potential COVID-19 Treatment

Albariqi et al., International Journal of Pharmaceutics, doi:10.1016/j.ijpharm.2022.121688

Albariqi et al., Pharmacokinetics and Safety of Inhaled Ivermectin in Mice as a Potential COVID-19 Treatment, International Journal of Pharmaceutics, doi:10.1016/j.ijpharm.2022.121688

Mar 2022 Source PDF

Twitter
Facebook

All Studies Meta

Mouse study of an inhaled ivermectin formulation, showing high concentrations in the lung and bronchoalveolar lavage fluid, exceeding the required concentration for efficacy based on in vitro studies.

Important missing comments or errors? Let us know.

Albariqi et al., 18 Mar 2022, peer-reviewed, 9 authors.

All Studies Meta Analysis Submit Updates or Corrections

This Paper Ivermectin All

Pharmacokinetics and safety of inhaled ivermectin in mice as a potential COVID-19 treatment

Ahmed H Albariqi, Yuncheng Wang, Rachel Yoon Kyung Chang, Diana H Quan, Xiaonan Wang, Stefanie Kalfas, John Drago, Warwick J Britton, Hak-Kim Chan

International Journal of Pharmaceutics, doi:10.1016/j.ijpharm.2022.121688

This is a PDF file of an article that has undergone enhancements after acceptance, such as the addition of a cover page and metadata, and formatting for readability, but it is not yet the definitive version of record. This version will undergo additional copyediting, typesetting and review before it is published in its final form, but we are providing this version to give early visibility of the article. Please note that, during the production process, errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.

References

Albariqi, Conceptualization, Methodology, Investigation, Formal analysis, Data curation, Visualization

Albariqi, Ke, Khanal, Kalfas, Tang et al., Preparation and Characterisation of inhalable ivermectin powders as a potential COVID-19 therapy, J. Aerosol Med. Pulm. Drug Deliv

Callaway, Omicron likely to weaken COVID vaccine protection, Nature

Caly, Druce, Catton, Jans, Wagstaff, The FDAapproved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro, Antiviral Res

Chaccour, Abizanda, Irigoyen-Barrio, Casellas, Aldaz et al., Nebulized ivermectin for COVID-19 and other respiratory diseases, a proof of concept, dose-ranging study in rats, Sci. Rep

Chaccour, Hammann, Rabinovich, Ivermectin to reduce malaria transmission I. Pharmacokinetic and pharmacodynamic considerations regarding efficacy and safety, Malar. J

Competing Interest, Hkc, AHA are inventors of a provisional patent

Cornberg, Buti, Eberhardt, Grossi, Shouval, EASL position paper on the use of COVID-19 vaccines in patients with chronic liver diseases, hepatobiliary cancer and liver transplant recipients, J. Hepatol

Errecalde, Lifschitz, Vecchioli, Ceballos, Errecalde et al., Safety and Pharmacokinetic Assessments of a Novel Ivermectin Nasal Spray Formulation in a Pig Model, J. Pharm. Sci

Gatti, De Ponti, Drug Repurposing in the COVID-19 Era: Insights from Case Studies Showing Pharmaceutical Peculiarities, Pharmaceutics

Gilbert, Slechta, A Case of Ivermectin-Induced Warfarin Toxicity: First Published Report, Hosp. Pharm

Guzzo, Furtek, Porras, Chen, Tipping et al., Safety, tolerability, and pharmacokinetics of escalating high doses of ivermectin in healthy adult subjects, J. Clin. Pharmacol

Hadj Hassine, Covid-19 vaccines and variants of concern: A review, Rev. Med. Virol

Kumar, Ter Ellen, Bouma, Troost, Van De Pol et al., Moxidectin and Ivermectin Inhibit Sars-Cov-2 Replication in Vero E6 Cells but Not in Human Primary Airway Epithelium Cells, Antimicrob. Agents Chemother

Lespine, Alvinerie, Sutra, Pors, Chartier, Influence of the route of administration on efficacy and tissue distribution of ivermectin in goat, Vet. Parasitol

Lifschitz, Virkel, Sallovitz, Sutra, Galtier et al., Comparative distribution of ivermectin and doramectin to parasite location tissues in cattle, Vet. Parasitol

Lundberg, Pinkham, Baer, Amaya, Narayanan et al., Nuclear import and export inhibitors alter capsid protein distribution in mammalian cells and reduce Venezuelan Equine Encephalitis Virus replication, Antiviral Res

Lv, Liu, Wang, Dang, Qiu et al., Ivermectin inhibits DNA polymerase UL42 of pseudorabies virus entrance into the nucleus and proliferation of the virus in vitro and vivo, Antiviral Res

Mansour, Shamma, Ahmed, Sabry, Esmat et al., Safety of inhaled ivermectin as a repurposed direct drug for treatment of COVID-19: A preclinical tolerance study, Int. Immunopharmacol

Mastrangelo, Pezzullo, De Burghgraeve, Kaptein, Pastorino et al., Ivermectin is a potent inhibitor of flavivirus replication specifically targeting NS3 helicase activity: new prospects for an old drug, J. Antimicrob. Chemother

Nicolas, Maia, Bassat, Kobylinski, Monteiro et al., Safety of oral ivermectin during pregnancy: a systematic review and meta-analysis, Lancet Glob Health

Omura, Crump, Ivermectin: panacea for resource-poor communities?, Trends Parasitol

Omura, Ivermectin: 25 years and still going strong, Int J Antimicrob Agents

Phillips, Inhaled efficacious dose translation from rodent to human: A retrospective analysis of clinical standards for respiratory diseases, Pharmacol. Ther

Pilcer, Amighi, Formulation strategy and use of excipients in pulmonary drug delivery, Int. J. Pharm

Qiu, Liao, Chow, Lam, Intratracheal Administration of Dry Powder Formulation in Mice, J Vis Exp

Quan, Conceptualization, Validation, Data curation

Sallam, COVID-19 Vaccine Hesitancy Worldwide: A Concise Systematic Review of Vaccine Acceptance Rates, Vaccines

Walters, Lung lining liquid -the hidden depths. The 5th Nils W. Svenningsen memorial lecture, Biol. Neonate

Wang, Methodology, Investigation. Stefanie Kalfas: Formal analysis, Data curation, Writing-review & editing John Drago: Formal analysis, Data curation, Writing -review & editing Warwick J Britton: Conceptualization, Resources, Supervision, Writing-review & editing

Wang, Validation, Methodology, Investigation, Formal analysis, Data curation

Wouters, Shadlen, Salcher-Konrad, Pollard, Larson et al., Challenges in ensuring global access to COVID-19 vaccines: production, affordability, allocation, and deployment, Lancet

Yoon, Chang, Conceptualization, Validation, Data curation

Zhang, Huo, Zhou, Xie, PKSolver: An add-in program for pharmacokinetic and pharmacodynamic data analysis in Microsoft Excel, Comput. Methods Programs Biomed

Download Image

Please send us corrections, updates, or comments. Vaccines and treatments are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment, vaccine, or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.

Submit